QUBT — what changed in the latest 10-Q
A section-by-section comparison of QUBT's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-10 vs the prior 10-Q · 2026-05-11
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +7 | −6 | ~19 | 13 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | +3 | −2 | ~3 | 6 |
| Legal proceedings | Text added/removed | +3 | −4 | ~2 | 3 |
| Risk factors | Some risk factors updated | +19 | −1 | ~3 | 7 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-10
The acquisition of NHanced significantly enhances the Company's nanophotonics manufacturing and advanced packaging capabilities and strengthens QCi’s ability to execute its long-term growth strategy. With NHanced's proven fabrication assets and deep technical expertise, the Company expects to accele…
Our ability to attract, develop, and retain engineers, scientists, and other key personnel is critical to executing our roadmap. The integration of LSI, NuCrypt and NHanced, the scaling of our Arizona Chips Facility and the expansion of “FAB 2”
will require additional investment, and execution outcomes will influence product cost, time-to-market, and margin profile. See “Liquidity and Capital Resources.”
Gross profit (loss) for the three months ended June 30, 2026 was a loss of $1.2 million compared to $26 thousand for the comparable prior year period. Gross profit (loss) for the six months ended June 30, 2026 was a loss of $1.9 million compared to $39 thousand for the comparable prior year period. …
Net cash used in operating activities for the six months ended June 30, 2026 was $23.3 million compared to $10.5 million for the same period in 2025. Cash used in the six months ended June 30, 2026 consisted of net loss of $15.8 million and a change in operating assets and liabilities of $(14.9) mil…
Text removed vs the prior filing · source: 10-Q · 2026-05-11
Our ability to attract, develop, and retain engineers, scientists, and other key personnel is critical to executing our roadmap. The integration of LSI and the scaling of our Arizona Chips Facility and planned “FAB 2” will require additional investment, and execution outcomes will influence product …
Gross margin for the three months ended March 31, 2026 was a loss of $0.7 million compared to $13 thousand for the comparable prior year period. The decrease in gross margin was largely due to under-absorption of fixed costs due to lower production volumes. We anticipate product gross margins will i…
Net decrease (increase) in cash and cash equivalents $(480,169) $87,484
Net cash used in operating activities for the three months ended March 31, 2026 was $9.4 million compared to $4.4 million for the same period in 2025. Cash used in the three months ended March 31, 2026 consisted of net loss of $4.1 million and a change in operating assets and liabilities of $5.7 mil…
Net cash used in investing activities for the three months ended March 31, 2026 and 2025 was $474.3 million and $1.7 million, respectively, and was attributable to net purchases of available for sale securities of $372.5 million, cash paid for acquisitions of $99.9 million and capital expenditures o…
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-10
evaluating the cost-benefit relationship of possible controls and procedures. The design of any controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under…
As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls …
These material weaknesses did not result in a material misstatement to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. However, if not remediated, these material weaknesses could result in a material misstatement to our annual or quarterly co…
Text removed vs the prior filing · source: 10-Q · 2026-05-11
As of the end of the period covered by this Quarterly Report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls …
These material weaknesses did not result in a material misstatement to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-10
On February 25, 2025, a class action lawsuit was filed against the Company and certain of its current and past officers in the New Jersey District Court, by a plaintiff seeking to represent a class of all persons who purchased the Company’s securities between March 30, 2020 and January 15, 2025, all…
On March 30, 2025, a shareholder derivative action (the “March 2025 Derivative Action”) was filed against certain of the Company’s current and past officers and directors, purportedly on behalf of the Company, in the United States District Court for the District of New Jersey, for alleged breaches o…
District Court for the District of New Jersey, specifically, the complaint alleges omissions and misrepresentations related to Quad M, QPhoton, NASA, millionways, and the TFLN foundry. The plaintiff seeks unspecified monetary damages plus attorney’s fees and costs. The Company and its board of direc…
Text removed vs the prior filing · source: 10-Q · 2026-05-11
There were no material developments during the quarter ended March 31, 2026 with respect to the BV Advisory matters that were resolved in 2025 as previously disclosed.
On February 25, 2025, a class action lawsuit was filed against the Company and certain of its current and past officers in the New Jersey District Court, by a plaintiff seeking to represent a class of all persons who purchased the Company’s securities between March 30, 2020 and January 15, 2025, all…
On May 6, 2025, a shareholder derivative action (the “May 2025 Derivative Action”) was filed against certain of the Company’s current and past officers and directors, purportedly on behalf of the Company , in the United States District Court for the District of New Jersey, for alleged breaches of fi…
There were no material developments during the quarter ended March 31, 2026 with respect to the BV Advisory matters that were resolved in 2025 as previously disclosed.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-10
shipments and increase cost of revenue. Any delay or unavailability of key products required for our development activities in a timely or cost-effective manner could delay or prevent us from further developing our products and services on our expected timelines or at all and could materially harm o…
Our use of generative AI tools may pose risks to our proprietary software and systems and subject us to legal liability.
We use generative AI tools in our business, and we expect to use generative AI tools in the future, including to generate code and other materials incorporated into our products, proprietary software and systems, and for other internal and external uses. Generative AI refers to deep-learning models …
such generative AI tools, and generative AI tools may also hallucinate, providing output that appears correct but is erroneous.
Additionally, while we employ practices designed to evaluate, track and mitigate risk around our use of third-party generative AI tools, our use of such tools may inadvertently violate a third party’s rights, be non-compliant with the applicable terms of use or our other legal obligations, or result…
Text removed vs the prior filing · source: 10-Q · 2026-05-11
Failure to execute effectively could delay product roadmaps, increase our cost structure and negatively impact revenue growth and margins.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice